Previous studies found SHMT2 to be overexpressed in various cancers, including B-cell lymphoma, thyroid cancer, and colorectal cancer, and it played an oncogenic role in these cancers [7,19,20]. This evidence concerns the gene SHMT2 and colorectal cancer.